Skip to main content

Table 3 Description of SF-36v2 and HJHS scores upon study entry and exit in 17 male subjects with severe/moderate HA on a LDDP regimen

From: Adherence to treatment regimen and bleeding rates in a prospective cohort of youth and young adults on low-dose daily prophylaxis for severe hemophilia A

  PCS MCS HJHS
Baseline End of study Baseline End of study Baseline End of study
Median 49.8 52.5 52.4 51.5 16.0 16.0
Minimum 40.0 40.7 33.6 32.6 0.0 0.0
Maximum 59.2 61.0 63.0 62.2 34.0 38.0
Mean 49.1 51.8 51.0 47.9 14.4 13.9
Standard Deviation 5.66 5.92 7.83 9.45 8.54 8.98
t-test -1.68 1.75 0.45
P value 0.11 0.10 0.66